LeadIQ logo
Learn more at LeadIQ.com
Cellenkos, Inc. logo

Cellenkos, Inc. Employee Directory

Biotechnology ResearchTexas, United States11-50 Employees

Cellenkos, Inc. is a clinical-stage biotechnology company focused on developing allogeneic, off-the-shelf regulatory T cell (Treg) therapies aimed at reducing inflammation and delivering durable immune modulation for inflammatory and autoimmune diseases. Its CRANE platform enables the selection and enrichment of cord blood-derived Tregs tailored to specific indications, supporting a pipeline that spans rare autoimmune blood disorders, oncology, neurodegenerative diseases, and inflammatory pulmonary disease. These Treg therapies do not require HLA matching, can be manufactured quickly, and are suitable for outpatient administration.

Headquartered in Houston, Texas, the company operates in the biotechnology research sector with a small-to-mid-sized team. It originated from licensing a cord blood Treg therapy platform from MD Anderson Cancer Center, anchoring its scientific foundation.

Find Cellenkos, Inc. employees' phone numbers or email addresses

Cellenkos, Inc. Global Highlights

Location
Employees

North America
14

Minus sign iconPlus sign icon
  • United States Of America
    14

Cellenkos, Inc.'s Leadership

  • Chief Operating Officer at Cellenkos, Inc.
    T. S.
    Chief Operating Officer
    Mobile Phone
  • Head Of Business Development at Cellenkos, Inc.
    J. W.
    Head Of Business Development
    Mobile Phone
  • Senior Manager Clinical Trial Studies at Cellenkos, Inc.
    S. M. E.
    Senior Manager Clinical Trial Studies
    Mobile Phone

Cellenkos, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Business Development
  • Community & Social Services
  • Consultant
  • Program & Project Management
  • Other
  • Biotechnology
  • Quality Assurance

Contact profiles from Cellenkos, Inc.

Name
Title
Contact
Location
Last Update
  • Chief Operating Officer at Cellenkos, Inc.
    T. S.
    Chief Operating Officer
    Mobile Phone
    United States, Mississippi
    Jun 08, 2026
  • Head Of Business Development at Cellenkos, Inc.
    J. W.
    Head Of Business Development
    Mobile Phone
    United States, New York
    Jun 01, 2026
  • Senior Manager Clinical Trial Studies at Cellenkos, Inc.
    S. M. E.
    Senior Manager Clinical Trial Studies
    Mobile Phone
    United States
    Apr 16, 2026

Frequently Asked Questions

What is Cellenkos, Inc. known for?

Minus sign iconPlus sign iconCellenkos, Inc. operates in the Biotechnology Research industry. Explore Cellenkos, Inc.'s company overview page for more information.

What is Cellenkos, Inc.'s most common email format?

Minus sign iconPlus sign iconCellenkos, Inc. employees' email format typically follows the pattern of First.Last@cellenkosinc.com. Trying to find reliable and up-to-date employee contact data? Find more Cellenkos, Inc. email formats with LeadIQ.

How many employees does Cellenkos, Inc. have currently?

Minus sign iconPlus sign iconCellenkos, Inc. has approximately 12 employees as of August 2026. These team members are located across 1 continents, including North America.

Who are Cellenkos, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Cellenkos, Inc.'s key employees include:

  • Chief Operating Officer: T. S.
  • Head Of Business Development: J. W.
  • Senior Manager Clinical Trial Studies: S. M. E.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

  • B2B data verified in real-time
  • Sync data to your CRM, & add it to an outreach sequence in one click
  • Integrations with your tech stack for optimal efficiency
  • A patented AI cold email generator
  • Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.